MAM
ICC scouts for official spirits partner for World Cup 2015
MUMBAI: The International Cricket Council (ICC) is inviting alcohol companies to submit proposals to become the official spirits partner of the ICC Cricket World Cup 2015 in Australia and New Zealand.
The successful applicant will receive marketing rights and benefits that will enable it to use valuable ICC intellectual property in association with its spirits brands. In addition to having the right to sell products through retail channels using the exclusive ICC Cricket World Cup 2015 event logo, the successful applicant will also supply product at all 14 venues of the event.
ICC GM commercial Campbell Jamieson said in a statement: “Responsible consumption of alcoholic spirits while watching sport has long been a part of the culture of Australia and New Zealand. The opportunity to become the official spirits partner of ICC is a valuable marketing and business opportunity for any spirits brand.”
The ICC is seeking companies with a proven track record in running national sponsorship marketing programs and supplying product at major sporting events, as well as sufficient human and financial resources to leverage the promotional opportunity.
“Proposals should clearly set out how the company will leverage the marketing rights granted to them to maximise association with ICC and enhance the status of this prestigious global sporting event,” Jamieson added.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
